On Monday, Janux Therapeutics Inc (NASDAQ: JANX) was 9.48% up from the session before settling in for the closing price of $28.8. A 52-week range for JANX has been $21.73 – $71.71.
During the last 5-year period, the sales drop of Healthcare Sector giant was -67.90%. When this article was written, the company’s average yearly earnings per share was at -56.99%. With a float of $53.79 million, this company’s outstanding shares have now reached $60.12 million.
Janux Therapeutics Inc (JANX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Janux Therapeutics Inc stocks. The insider ownership of Janux Therapeutics Inc is 10.56%, while institutional ownership is 107.10%. The most recent insider transaction that took place on Nov 14 ’25, was worth 99,990. In this transaction Chief Business Officer of this company sold 3,333 shares at a rate of $30.00, taking the stock ownership to the 84,974 shares. Before that another transaction happened on Nov 14 ’25, when Company’s Officer proposed sale 3,333 for $27.46, making the entire transaction worth $91,524.
Janux Therapeutics Inc (JANX) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.36 earnings per share (EPS) during the time that was better than consensus figure (set at -0.45) by 0.09. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.71 per share during the current fiscal year.
Janux Therapeutics Inc (NASDAQ: JANX) Trading Performance Indicators
You can see what Janux Therapeutics Inc (JANX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 35.86. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 189.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.68, a number that is poised to hit -0.66 in the next quarter and is forecasted to reach -2.93 in one year’s time.
Technical Analysis of Janux Therapeutics Inc (JANX)
Looking closely at Janux Therapeutics Inc (NASDAQ: JANX), its last 5-days average volume was 0.84 million, which is a drop from its year-to-date volume of 0.93 million. As of the previous 9 days, the stock’s Stochastic %D was 68.25%.
During the past 100 days, Janux Therapeutics Inc’s (JANX) raw stochastic average was set at 99.39%, which indicates a significant decrease from 99.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.04 in the past 14 days, which was higher than the 1.50 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $26.21, while its 200-day Moving Average is $26.91. However, in the short run, Janux Therapeutics Inc’s stock first resistance to watch stands at $32.41. Second resistance stands at $33.28. The third major resistance level sits at $35.00. If the price goes on to break the first support level at $29.82, it is likely to go to the next support level at $28.10. Should the price break the second support level, the third support level stands at $27.23.
Janux Therapeutics Inc (NASDAQ: JANX) Key Stats
There are 60,148K outstanding shares of the company, which has a market capitalization of 1.90 billion. As of now, sales total 10,590 K while income totals -68,990 K. Its latest quarter income was 10,000 K while its last quarter net income were -24,310 K.
